New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Michael Maes, Zdeněk Fišar, Miguel Medina, Giovanni Scapagnini, Gabriel Nowak, Michael Berk (2012). New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors. , 20(3), DOI: https://doi.org/10.1007/s10787-011-0111-7.